Clinical Trial Site

Jackson, Mississippi 39216

2 studies enrolling now · 7 studies all time

What they study most

Acid Cholesteryl Ester Hydrolase Deficiency, Type 2, Acid Lipase Deficiency, Breast Cancer, Cholesterol Ester Storage Disease, ER Positive Breast Cancer, Familial Amyloidotic Cardiomyopathy (FAC), HER2 Negative Breast Carcinoma, Hereditary Transthyretin-mediated (ATTRv) Amyloidosis, High Cardiovascular Risk, High Risk Cardiovascular Disease, Hypertension, LAL-Deficiency

Studies at this site

• Palazestrant in Combination With Ribociclib for the First-line Treatment of ER+/HER2- Advanced Breast Cancer — Recruiting now
• Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease — Recruiting now
• Lysosomal Acid Lipase (LAL) Deficiency Registry — Recruiting now
• A Study to Evaluate Efficacy and Safety of ALN-AGT01 in Patients With Mild To-Moderate Hypertension — Completed
• Zilebesiran as Add-on Therapy in Patients With Hypertension Not Adequately Controlled by a Standard of Care Antihypertensive Medication (KARDIA-2) — Completed
• A Multicenter Observational Study to Evaluate the Effectiveness of Patisiran in Patients With Polyneuropathy of ATTRv Amyloidosis With a V122I or T60A Mutation — Completed
• DISCOVERY: A Study Examining the Prevalence of TTR Mutations in Subjects Suspected of Having Cardiac Amyloidosis — Completed